These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6277122)

  • 1. Effects of two cholecystokinin variants, CCK-39 and CCK-8, on basal and stimulated insulin secretion.
    Ahrén B; Lundquist I
    Acta Diabetol Lat; 1981; 18(4):345-56. PubMed ID: 6277122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of gastric inhibitory polypeptide (GIP) and cholecystokinin (CCK-8) with basal and stimulated insulin secretion in mice.
    Ahrén B; Hedner P; Lundquist I
    Acta Endocrinol (Copenh); 1983 Jan; 102(1):96-102. PubMed ID: 6130663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of six cholecystokinin (CCK) fragments on insulin secretion in the mouse.
    Ahrén B; Hedner P; Lundquist I
    Acta Pharmacol Toxicol (Copenh); 1986 Feb; 58(2):115-20. PubMed ID: 3518338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin secretory response to different secretagogues in hyper- and hypothyroid mice.
    Ahrén B; Lundquist I
    Acta Endocrinol (Copenh); 1981 Aug; 97(4):508-13. PubMed ID: 6115531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenalectomy and chemical sympathectomy by 6-hydroxydopamine. Effects on basal and stimulated insulin secretion.
    Ahrén B; Lundquist I
    Pflugers Arch; 1981 Apr; 390(1):17-21. PubMed ID: 6264383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrin releasing peptide (GRP): effects on basal and stimulated insulin and glucagon secretion in the mouse.
    Pettersson M; Ahrén B
    Peptides; 1987; 8(1):55-60. PubMed ID: 3554168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of vasoactive intestinal polypeptide (VIP), secretin and gastrin on insulin secretion in the mouse.
    Ahrén B; Lundquist I
    Diabetologia; 1981; 20(1):54-9. PubMed ID: 7009286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of autonomic blockade by methylatropine and optical isomers and propranolol on plasma insulin levels in the basal state and after stimulation.
    Ahrén B; Lundquist I
    Acta Physiol Scand; 1981 May; 112(1):57-63. PubMed ID: 7025578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLP-1 and GLP-1(7-36) amide: influences on basal and stimulated insulin and glucagon secretion in the mouse.
    Fridolf T; Böttcher G; Sundler F; Ahrén B
    Pancreas; 1991 Mar; 6(2):208-15. PubMed ID: 1886889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of alpha-adrenoceptor blockade by phentolamine on basal and stimulated insulin secretion in the mouse.
    Ahrén B; Lundquist I
    Acta Physiol Scand; 1985 Oct; 125(2):211-7. PubMed ID: 2866660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of naloxone on basal and stimulated insulin secretion in the mouse.
    Ahrén B; Lundquist I
    Eur J Pharmacol; 1984 Jun; 102(1):135-9. PubMed ID: 6090153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cholecystokinin octapeptide and carbachol on neonatal insulin secretory dynamics.
    Fletcher DJ; Rowley WH; Brinn JE
    Regul Pept; 1989; 25(3):287-93. PubMed ID: 2672124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecystokinin-33 potentiates and vasoactive intestinal polypeptide inhibits gastric inhibitory polypeptide--induced insulin secretion in the perfused rat pancreas.
    Sandberg E; Ahrén B; Tendler D; Efendic S
    Acta Endocrinol (Copenh); 1988 Apr; 117(4):545-51. PubMed ID: 3291528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of three different cholecystokinin receptor antagonists on basal and stimulated insulin and glucagon secretion in mice.
    Karlsson S; Ahrén B
    Acta Physiol Scand; 1989 Mar; 135(3):271-8. PubMed ID: 2648765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous opioids modulate the effect of cholecystokinin on insulin release in dogs.
    Schusdziarra V; Lenz N; Rewes B; Pfeiffer EF
    Neuropeptides; 1984 Nov; 4(6):507-17. PubMed ID: 6096758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ca2+-independent phospholipase A2 contributes to the insulinotropic action of cholecystokinin-8 in rat islets: dissociation from the mechanism of carbachol.
    Simonsson E; Karlsson S; Ahrén B
    Diabetes; 1998 Sep; 47(9):1436-43. PubMed ID: 9726232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sulfation of CCK-8 on its stimulation of the endocrine and exocrine secretion from the isolated perfused porcine pancreas.
    Jensen SL; Holst JJ; Nielsen OV; Rehfeld JF
    Digestion; 1981; 22(6):305-9. PubMed ID: 6277714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cholecystokinin and glucagon-like peptide 1 on the secretion of pancreatic polypeptide in mice.
    Ahrén B; Gingerich RL; Havel PJ
    Regul Pept; 1995 Nov; 59(3):297-302. PubMed ID: 8577934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of beta-endorphin, met-enkephalin, and dynorphin A on basal and stimulated insulin secretion in the mouse.
    Ahrén B
    Int J Pancreatol; 1989 Sep; 5(2):165-78. PubMed ID: 2574736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of combined secretagogues and extracellular calcium on neonatal insulin release.
    Schuppin GT; Brinn JE; Fletcher DJ
    Regul Pept; 1990 Feb; 27(2):237-46. PubMed ID: 2158123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.